LAWTON ALISON FRANCIS

Director at Dianthus Therapeutics, Inc. /DE/ · on record since May 22, 2026
Director at ProQR Therapeutics N.V. · on record since Mar 18, 2026
Director at CUBIST PHARMACEUTICALS INC · on record since Feb 17, 2012
Director at Verastem, Inc. · on record since Nov 27, 2012
Chief Operating Officer at Tempest Therapeutics, Inc. · on record since Mar 11, 2013
Director at CoLucid Pharmaceuticals, Inc. · on record since Mar 15, 2016
Director at Kaleido Biosciences, Inc. · on record since Feb 27, 2019
See Remarks at Kaleido Biosciences, Inc. · on record since Feb 27, 2019
Director at Spyre Therapeutics, Inc. · on record since Dec 17, 2020
Director at X4 Pharmaceuticals, Inc · on record since Oct 6, 2020

Insider trading activity of LAWTON ALISON FRANCIS

Transactions on record: 58; since Feb 17, 2012

Open-market buys: 1; $22.9K

Open-market sells: 0

Companies traded: 8; last filing May 22, 2026

Figures computed from official regulatory filings — methodology.

Companies where LAWTON ALISON FRANCIS has traded

Dianthus Therapeutics, Inc. /DE/7 tx · May 22, 2026
X4 Pharmaceuticals, Inc5 tx · $57K · Jun 11, 2024
Spyre Therapeutics, Inc.4 tx · Jun 30, 2023
Kaleido Biosciences, Inc.4 tx · Apr 17, 2020
Verastem, Inc.10 tx · $22.9K · Jun 25, 2019
CoLucid Pharmaceuticals, Inc.6 tx · $441.7K · Mar 1, 2017
CUBIST PHARMACEUTICALS INC20 tx · $921.2K · Jan 21, 2015
Tempest Therapeutics, Inc.2 tx · Jun 11, 2013

Track record of LAWTON ALISON FRANCIS

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of LAWTON ALISON FRANCIS

Co-insiders of LAWTON ALISON FRANCIS

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Dianthus Therapeutics, Inc. /DE/	May 22, 2026	AwardD	6,090	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	May 22, 2025	AwardD	12,500	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Jun 11, 2024	Award	45,000	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	May 28, 2024	AwardD	11,000	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	Sep 13, 2023	AwardD	6,500	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 30, 2023	AwardD	1,950,000	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Jun 14, 2023	Award	45,000	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	Jun 30, 2022	AwardD	20,000	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Jun 27, 2022	Award	6,667	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 10, 2022	AwardD	43,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 9, 2021	AwardD	40,000	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	Jun 3, 2021	AwardD	18,188	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Jun 2, 2021	AwardD	6,000	9.50 USD	$57K	SEC
Dianthus Therapeutics, Inc. /DE/	Dec 23, 2020	AwardD	36,377	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Dec 17, 2020	AwardD	47,200	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Oct 6, 2020	AwardD	6,854	0.00 USD	$0	SEC
Kaleido Biosciences, Inc.	Apr 17, 2020	AwardD	118,500	0.00 USD	$0	SEC
Kaleido Biosciences, Inc.	Mar 3, 2020	AwardD	46,325	0.00 USD	$0	SEC
Kaleido Biosciences, Inc.	Nov 18, 2019	AwardD	-150,000	0.00 USD	$0	SEC
Verastem, Inc.	Jun 25, 2019	AwardD	25,000	0.00 USD	$0	SEC
Kaleido Biosciences, Inc.	Mar 4, 2019	AwardD	150,000	0.00 USD	$0	SEC
Verastem, Inc.	Feb 13, 2019	AwardD	25,000	0.00 USD	$0	SEC
Verastem, Inc.	Jun 15, 2017	AwardD	25,000	0.00 USD	$0	SEC
CoLucid Pharmaceuticals, Inc.	Mar 1, 2017	OtherD	-658	10.30 USD	$6.8K	SEC
CoLucid Pharmaceuticals, Inc.	Mar 1, 2017	OtherD	-8,897	40.26 USD	$358.2K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Dianthus Therapeutics, Inc. /DE/	May 22, 2026	AwardD	6,090	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	May 22, 2025	AwardD	12,500	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Jun 11, 2024	Award	45,000	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	May 28, 2024	AwardD	11,000	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	Sep 13, 2023	AwardD	6,500	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 30, 2023	AwardD	1,950,000	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Jun 14, 2023	Award	45,000	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	Jun 30, 2022	AwardD	20,000	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Jun 27, 2022	Award	6,667	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 10, 2022	AwardD	43,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 9, 2021	AwardD	40,000	0.00 USD	$0	SEC
Dianthus Therapeutics, Inc. /DE/	Jun 3, 2021	AwardD	18,188	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Jun 2, 2021	AwardD	6,000	9.50 USD	$57K	SEC
Dianthus Therapeutics, Inc. /DE/	Dec 23, 2020	AwardD	36,377	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Dec 17, 2020	AwardD	47,200	0.00 USD	$0	SEC
X4 Pharmaceuticals, Inc	Oct 6, 2020	AwardD	6,854	0.00 USD	$0	SEC
Kaleido Biosciences, Inc.	Apr 17, 2020	AwardD	118,500	0.00 USD	$0	SEC
Kaleido Biosciences, Inc.	Mar 3, 2020	AwardD	46,325	0.00 USD	$0	SEC
Kaleido Biosciences, Inc.	Nov 18, 2019	AwardD	-150,000	0.00 USD	$0	SEC
Verastem, Inc.	Jun 25, 2019	AwardD	25,000	0.00 USD	$0	SEC
Kaleido Biosciences, Inc.	Mar 4, 2019	AwardD	150,000	0.00 USD	$0	SEC
Verastem, Inc.	Feb 13, 2019	AwardD	25,000	0.00 USD	$0	SEC
Verastem, Inc.	Jun 15, 2017	AwardD	25,000	0.00 USD	$0	SEC
CoLucid Pharmaceuticals, Inc.	Mar 1, 2017	OtherD	-658	10.30 USD	$6.8K	SEC
CoLucid Pharmaceuticals, Inc.	Mar 1, 2017	OtherD	-8,897	40.26 USD	$358.2K	SEC